IgG at Dr. Essa Lab

IgG at Dr. Essa Lab

Immunoglobulin G (IgG) is the most abundant class of antibody in human serum, constituting approximately 75% to 80% of all circulating immunoglobulins. Produced by specialized plasma cells (differentiated B lymphocytes), IgG plays a fundamental role in the body’s secondary immune response, providing long-term humoral immunity against a vast array of bacterial, viral, and fungal pathogens. It is uniquely structured with two heavy and two light chains, forming a Y-shape that features antigen-binding Fab fragments and an effector Fc region. Crucially, IgG is the only immunoglobulin class capable of crossing the human placenta, thereby transferring vital maternal passive immunity to the developing fetus. At Dr. Essa Lab, a premier diagnostic institution in Pakistan, the IgG test is performed using state-of-the-art immunological assays to measure the precise concentration of these antibodies in the blood. This quantitative analysis is essential for evaluating a patient’s immune status, diagnosing primary and secondary immunodeficiency disorders, monitoring chronic infections, and investigating autoimmune conditions.

The clinical importance of measuring serum IgG levels cannot be overstated. A deficiency in IgG can leave a patient highly susceptible to recurrent, severe, or opportunistic infections, particularly of the respiratory and gastrointestinal tracts. Conversely, elevated levels of IgG often signal chronic immune stimulation, which may stem from persistent infections, active autoimmune diseases, chronic inflammatory states, or plasma cell dyscrasias such as multiple myeloma. By utilizing highly sensitive diagnostic technology, Dr. Essa Lab provides clinicians with accurate, reproducible IgG measurements that serve as a cornerstone for clinical decision-making. Whether used as a screening tool for suspected immunodeficiency or as a monitoring parameter for patients undergoing immunoglobulin replacement therapy, the IgG test at Dr. Essa Lab delivers high diagnostic value, helping to guide targeted therapeutic interventions and improve patient outcomes.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the accuracy and reliability of the IgG test results. Patients undergoing this investigation should observe the following guidelines:

• No Fasting Required: Fasting is generally not necessary for a serum IgG test. You may eat and drink normally prior to your appointment unless instructed otherwise for concurrent tests.
• Medication Disclosure: Inform your prescribing physician and the laboratory staff at Dr. Essa Lab about all medications you are currently taking. Immunosuppressants, corticosteroids, chemotherapy drugs, and recent immunoglobulin replacement therapies (IVIG or SCIG) can significantly alter your circulating IgG levels.
• Vaccination History: Disclose any recent vaccinations, as immunization can temporarily stimulate antibody production and influence test interpretations.
• Hydration: Drink plenty of water before the blood draw. Being well-hydrated makes your veins more accessible, facilitating a smoother and more comfortable venipuncture process.
• Follow Specific Clinical Advice: Always adhere to any additional, personalized instructions provided by your referring doctor regarding your diagnostic testing.

During the Procedure

The IgG test is a straightforward, minimally invasive blood test performed by highly trained phlebotomists at Dr. Essa Lab. The procedure involves the following steps:

• Patient Identification and Verification: The phlebotomist will verify your identity and confirm the specific test requested to ensure patient safety and diagnostic accuracy.
• Positioning: You will be seated comfortably in a blood collection chair, and your arm will be positioned on a supportive rest.
• Site Selection and Cleansing: The phlebotomist will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The selected site is then thoroughly cleansed with an antiseptic solution (such as isopropyl alcohol) and allowed to air dry.
• Tourniquet Application: A sterile elastic tourniquet is tied around your upper arm to temporarily restrict venous blood flow, making the veins more prominent and easier to access.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a serum separator tube with a gold or red top) is gently inserted into the vein. You may feel a brief, mild pinch or prick.
• Sample Collection: Blood flows naturally into the vacuum tube. Once the required volume of blood is collected, the tourniquet is released, and the needle is carefully withdrawn.
• Post-Draw Care: A sterile cotton ball or gauze pad is immediately applied to the puncture site with gentle pressure to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then placed over the site.
• Duration and Safety: The entire venipuncture process takes less than five minutes. All equipment used is strictly sterile and disposable, eliminating any risk of cross-contamination.

When is a IgG Performed?

Evaluation of Recurrent, Severe, or Chronic Infections

Physicians frequently request an IgG test when a patient presents with a history of recurrent, unusually severe, or chronic infections. This includes frequent episodes of otitis media (ear infections), sinusitis, bronchitis, or pneumonia. When the body’s primary defense mechanisms are compromised, pathogens can repeatedly colonize the respiratory and gastrointestinal tracts. Measuring serum IgG levels helps determine if an underlying antibody deficiency is preventing the immune system from mounting an effective secondary response, thereby allowing infections to recur or persist despite standard antibiotic therapy.

Diagnosis and Classification of Primary Immunodeficiency Diseases

An IgG test is a critical initial step in diagnosing primary immunodeficiency diseases (PIDs). These are congenital disorders characterized by genetic mutations that impair the development or function of the immune system. Conditions such as Common Variable Immunodeficiency (CVID), Selective IgG Subclass Deficiency, and X-Linked Agammaglobulinemia (Bruton’s disease) directly impact IgG production. By quantifying serum IgG levels, immunologists can identify these rare but serious conditions early in life or during adulthood, enabling the initiation of life-saving therapies such as immunoglobulin replacement.

Assessment of Secondary Immunodeficiencies

Secondary or acquired immunodeficiencies occur when external factors, diseases, or medical treatments suppress the immune system. Clinicians order an IgG test to assess immune function in patients undergoing chemotherapy, radiation therapy, or long-term immunosuppressive treatment for organ transplants or autoimmune disorders. Additionally, chronic infections like HIV/AIDS, hematological malignancies such as leukemia or lymphoma, and protein-losing states can severely deplete IgG levels. Monitoring IgG levels in these patients is vital to evaluate their susceptibility to opportunistic infections and determine the need for prophylactic measures.

Investigation of Autoimmune and Chronic Inflammatory Disorders

In patients suspected of having autoimmune or chronic inflammatory diseases, the immune system becomes hyperactive and produces excessive amounts of antibodies, including IgG, directed against the body’s own tissues. An IgG test is performed to detect polyclonal hypergammaglobulinemia, which is commonly associated with systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjögren’s syndrome, and chronic active hepatitis. Identifying elevated IgG levels assists rheumatologists and gastroenterologists in confirming a diagnosis, assessing disease activity, and monitoring the effectiveness of anti-inflammatory or immunomodulatory therapies.

Screening and Monitoring of Plasma Cell Disorders

Plasma cell dyscrasias are clonal disorders characterized by the uncontrolled proliferation of a single clone of plasma cells, leading to the overproduction of a specific monoclonal immunoglobulin (M-protein). An IgG test, often performed alongside serum protein electrophoresis (SPEP) and immunofixation, is crucial for screening, diagnosing, and monitoring conditions like Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance (MGUS). Tracking the quantitative levels of IgG over time allows oncologists and hematologists to evaluate tumor burden, assess response to chemotherapy, and detect early signs of disease relapse.

What Does a IgG Detect?

The quantitative measurement of serum Immunoglobulin G (IgG) at Dr. Essa Lab can detect, evaluate, and assist in the management of numerous clinical conditions and physiological states, including:

• Common Variable Immunodeficiency (CVID): A primary immunodeficiency characterized by significantly reduced serum IgG levels, leading to recurrent bacterial infections.
• Selective IgG Subclass Deficiency: A condition where total IgG may be near normal, but one or more specific subclasses (IgG1, IgG2, IgG3, or IgG4) are deficient.
• X-Linked Agammaglobulinemia (Bruton’s Disease): A severe genetic disorder resulting in a near-total absence of B cells and extremely low levels of all immunoglobulins, including IgG.
• Multiple Myeloma (IgG Type): A hematological malignancy characterized by a massive, monoclonal spike in IgG levels produced by malignant plasma cells.
• Monoclonal Gammopathy of Undetermined Significance (MGUS): A premalignant plasma cell disorder presenting with a stable, low-level monoclonal IgG band.
• Chronic Lymphocytic Leukemia (CLL): A slow-growing leukemia that often leads to secondary hypogammaglobulinemia due to impaired normal B-cell function.
• Systemic Lupus Erythematosus (SLE): An autoimmune disease frequently associated with polyclonal hypergammaglobulinemia and elevated IgG levels.
• Rheumatoid Arthritis (RA): A chronic inflammatory joint disease that can cause systemic immune activation and elevated serum IgG.
• Sjögren’s Syndrome: An autoimmune disorder affecting exocrine glands, often characterized by highly elevated polyclonal IgG levels.
• Autoimmune Hepatitis: A chronic inflammatory liver disease where elevated IgG levels serve as a key diagnostic marker.
• Liver Cirrhosis: Advanced liver scarring that leads to impaired protein clearance and a characteristic polyclonal rise in immunoglobulins.
• Sarcoidosis: A systemic granulomatous disease that frequently presents with elevated serum IgG levels due to chronic immune stimulation.
• Nephrotic Syndrome: A kidney disorder causing excessive protein loss in the urine, which can result in low serum IgG levels.
• Protein-Losing Enteropathy: A gastrointestinal condition characterized by the loss of serum proteins, including IgG, into the gut lumen.
• Severe Burns: Extensive skin damage leading to massive capillary leakage and systemic loss of immunoglobulins, causing temporary hypogammaglobulinemia.
• Severe Malnutrition: A state of nutritional deprivation that impairs the liver’s and immune system’s ability to synthesize proteins and antibodies.
• Wiskott-Aldrich Syndrome: A rare X-linked recessive disease characterized by eczema, thrombocytopenia, and immune deficiency with variable IgG levels.
• Hyper-IgM Syndrome: A genetic defect in class-switch recombination, resulting in elevated or normal IgM but severely decreased IgG and IgA.
• Transient Hypogammaglobulinemia of Infancy: A temporary delay in an infant’s ability to produce their own immunoglobulins after maternal IgG decays.
• Chronic Bacterial Infections: Persistent bacterial diseases, such as tuberculosis or osteomyelitis, which stimulate a prolonged polyclonal IgG response.
• Chronic Viral Infections: Long-term viral conditions, including HIV, Epstein-Barr Virus (EBV), and Cytomegalovirus (CMV), which drive elevated IgG production.
• Parasitic Infections: Chronic parasitic diseases, such as visceral leishmaniasis, which can cause profound hypergammaglobulinemia.
• Drug-Induced Hypogammaglobulinemia: Reduced IgG levels caused by medications such as rituximab, phenytoin, carbamazepine, or long-term corticosteroids.
• Non-Hodgkin Lymphoma: Lymphatic cancers that can disrupt normal antibody production, leading to either elevated monoclonal or decreased polyclonal IgG.
• IgG4-Related Disease: A systemic fibroinflammatory condition characterized by tumefactive lesions and highly elevated serum levels of the IgG4 subclass.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is committed to delivering highly accurate diagnostic results with optimal efficiency. Utilizing advanced, fully automated immunoassay platforms, our dedicated pathology department processes serum IgG tests under strict quality control protocols. The typical turnaround time for a quantitative serum IgG test is 24 to 48 hours from the time of sample collection. This rapid processing ensures that referring physicians receive timely data to make critical clinical decisions without unnecessary delay.

Patients can access their diagnostic reports through several convenient channels. Once the report is verified by our consultant pathologists, an automated SMS notification containing a secure link is sent directly to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed online via the official Dr. Essa Lab web portal or mobile application. Additionally, physical copies of the reports can be collected from any of our numerous diagnostic centers and collection points located across Karachi and other major cities in Pakistan, ensuring seamless access for all patients.

IgG Findings Overview

The following table provides an overview of the parameters evaluated during a quantitative serum IgG test, along with typical normal ranges and possible clinical implications of abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Total Serum IgG (Adults)	700 – 1600 mg/dL	Elevated: Chronic infections, autoimmune diseases, liver disease, IgG multiple myeloma. Decreased: CVID, secondary immunodeficiency, nephrotic syndrome, severe burns.
IgG Subclass 1 (IgG1)	380 – 930 mg/dL	Elevated: Chronic immune activation. Decreased: Recurrent pyogenic infections, often associated with IgG3 deficiency.
IgG Subclass 2 (IgG2)	120 – 580 mg/dL	Elevated: Autoimmune disorders. Decreased: Recurrent sinopulmonary infections with encapsulated bacteria (e.g., S. pneumoniae).
IgG Subclass 3 (IgG3)	20 – 110 mg/dL	Elevated: Chronic viral infections. Decreased: Recurrent respiratory tract infections, often associated with IgG1 deficiency.
IgG Subclass 4 (IgG4)	4 – 120 mg/dL	Elevated: IgG4-related disease, chronic allergen exposure, asthma. Decreased: Rarely clinically significant in isolation.
Neonatal/Cord Blood IgG	Comparable to or slightly higher than maternal levels	Decreased: Prematurity, maternal hypogammaglobulinemia, placental transfer defects.
Serum Immunofixation	Polyclonal pattern (normal distribution of antibodies)	Monoclonal Band (M-Spike): Indicates clonal plasma cell proliferation, suggestive of Multiple Myeloma or MGUS.
Specimen Integrity	Clear, non-hemolyzed, non-lipemic serum	Hemolyzed or Lipemic: May interfere with optical immunoassay measurements, requiring sample recollection.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for IgG?

• ISO 15189 Certified Laboratories: Dr. Essa Lab operates under international quality standards, ensuring the highest level of accuracy and reliability in pathology testing.
• Pioneering Diagnostic Excellence: Serving Pakistan since 1987, Dr. Essa Lab is one of the country’s most trusted and established diagnostic networks.
• Advanced Automated Analyzers: We utilize cutting-edge nephelometry and chemiluminescent immunoassay (CLIA) technologies for precise antibody quantification.
• Expert Consultant Pathologists: All specialized immunology reports are reviewed and verified by highly qualified consultant pathologists and immunologists.
• Convenient Home Sample Collection: Patients can avail of our professional home sample collection services across Karachi and other major cities for maximum convenience.
• Secure Online Report Portal: Access your diagnostic reports instantly from the comfort of your home via our user-friendly website or mobile application.
• Rigorous Quality Assurance: We participate in strict internal and external quality control programs (EQAS) to maintain international testing standards.
• Patient-Centric Care: Dr. Essa Lab is dedicated to providing compassionate, affordable, and professional diagnostic services tailored to patient needs.